Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWitan Regulatory News (WTAN)

  • This share is currently suspended. It was suspended at a price of 266.00
  • There is currently no data for WTAN

Share buyback authority

1 Feb 2024 07:00

RNS Number : 6021B
Witan Investment Trust PLC
01 February 2024
 

WITAN INVESTMENT TRUST PLC

Share Buyback Authority

 

1 February 2024

Witan Investment Trust plc ("the Company") announces that pursuant to its ongoing share buyback programme and in order to remove the administrative burden of overseeing share buybacks on a day-to-day basis from the Company's management team, it has entered into an irrevocable non-discretionary agreement with J.P. Morgan Securities plc ("JPMS plc") pursuant to which JPMS plc will acquire ordinary shares in the Company, within certain pre-set parameters, for subsequent sale on to and purchase by the Company. Shares bought back are held in treasury and will be re-sold only at, or at a premium to, the prevailing net asset value at the time of issue.

JPMS plc will make its trading decisions in relation to the ordinary shares independently of, and uninfluenced by, the Company. The agreement will terminate at the Company's next annual general meeting (scheduled to be held on 1 May 2024), after which it may be renewed. Purchases will be made within the authorities granted by shareholders at the Company's annual general meeting held on 4 May 2023 at which shareholders approved that the Company be authorised to make market purchases of its own ordinary shares up to a maximum of 99,028,329 ordinary shares, being 14.99% of the ordinary shares then in issue. Since the Company's annual general meeting on 4 May 2023 the Company has repurchased 38,807,896 ordinary shares, leaving an authorised share buyback balance of up to 60,220,433 ordinary shares as at 31 January 2024.

This arrangement is in accordance with Chapter 12 of the UKLA Listing Rules and the Company's general authority to repurchase shares. No maximum pecuniary amount has been allocated to the Programme by the Company but repurchases will be conducted in accordance with the Company's established practice, the Listing Rules and applicable regulation.

As in recent years, the buyback will continue to be undertaken in order to provide liquidity in the market, while being accretive to the net asset value and helping to moderate discount volatility.

-ENDS-

 

For further information please contact:

Andrew Bell, Chief Executive Officer

Witan Investment Trust plc

Tel: 020 7227 9770

Andrew.Bell@witan.co.uk

 

James Hart, Investment Director

Witan Investment Trust plc

Tel: 020 7227 9770

James.Hart@witan.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUAVBRSVUAOAR
Date   Source Headline
13th Mar 20245:41 pmRNSTransaction in Own Shares
13th Mar 20241:10 pmRNSNet Asset Value(s)
13th Mar 20249:35 amRNSPresentation- Investor Meet Company change of date
12th Mar 20245:09 pmRNSTransaction in Own Shares
12th Mar 20244:35 pmRNSPortfolio Listing as at 29 February 2024
12th Mar 20244:24 pmRNSMonthly Factsheet as at 29 February 2024
12th Mar 202412:39 pmRNSNet Asset Value(s)
11th Mar 20245:27 pmRNSTransaction in Own Shares
11th Mar 202412:44 pmRNSNet Asset Value(s)
8th Mar 20245:16 pmRNSTransaction in Own Shares
8th Mar 20242:08 pmRNSNet Asset Value(s)
7th Mar 20245:09 pmRNSTransaction in Own Shares
7th Mar 202412:29 pmRNSNet Asset Value(s)
6th Mar 20245:21 pmRNSTransaction in Own Shares
6th Mar 20244:19 pmRNSHolding(s) in Company
6th Mar 202412:08 pmRNSNet Asset Value(s)
5th Mar 20245:26 pmRNSTransaction in Own Shares
5th Mar 202412:13 pmRNSNet Asset Value(s)
4th Mar 20245:20 pmRNSTransaction in Own Shares
4th Mar 202412:55 pmRNSNet Asset Value(s)
1st Mar 20245:28 pmRNSTransaction in Own Shares
1st Mar 20242:13 pmRNSNet Asset Value(s)
1st Mar 202410:46 amRNSTotal Voting Rights
29th Feb 20245:13 pmRNSTransaction in Own Shares
29th Feb 20241:50 pmRNSNet Asset Value(s)
28th Feb 20245:00 pmRNSTransaction in Own Shares
28th Feb 202412:27 pmRNSNet Asset Value(s)
27th Feb 20245:11 pmRNSTransaction in Own Shares
27th Feb 20241:03 pmRNSNet Asset Value(s)
27th Feb 20249:00 amRNSResults Presentation via Investor Meet Company
26th Feb 20245:14 pmRNSTransaction in Own Shares
26th Feb 20241:25 pmRNSNet Asset Value(s)
23rd Feb 20244:59 pmRNSTransaction in Own Shares
23rd Feb 202412:44 pmRNSNet Asset Value(s)
22nd Feb 20245:08 pmRNSTransaction in Own Shares
22nd Feb 202412:19 pmRNSNet Asset Value(s)
21st Feb 20245:16 pmRNSTransaction in Own Shares
21st Feb 20242:57 pmRNSNet Asset Value(s)
20th Feb 20245:24 pmRNSTransaction in Own Shares
20th Feb 20241:01 pmRNSNet Asset Value(s)
19th Feb 20245:10 pmRNSTransaction in Own Shares
19th Feb 20241:06 pmRNSNet Asset Value(s)
16th Feb 20245:19 pmRNSTransaction in Own Shares
16th Feb 20241:21 pmRNSNet Asset Value(s)
15th Feb 20245:03 pmRNSTransaction in Own Shares
15th Feb 202412:26 pmRNSNet Asset Value(s)
14th Feb 20245:16 pmRNSTransaction in Own Shares
14th Feb 20241:24 pmRNSNet Asset Value(s)
14th Feb 202411:49 amRNSPortfolio Listing as at 31 January 2024
13th Feb 20245:22 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.